DecaplaninAlternative Names: M 861410
Latest Information Update: 01 Sep 1994
At a glance
- Originator Aventis
- Class Antibacterials; Peptide antibiotics
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bacterial infections